A variety of pathologies of autoimmune diseases and allergic diseases are caused by the immune responses to self, environmental nonmicrobial antigens, and infectious agents. Regulatory T cells (T~reg~ cells), which are characterized by expression of the Forkhead transcription factor, Foxp3, play an indispensable role in immunological tolerance, protecting the host from excessive immune responses ([@bib12]; [@bib28]; [@bib29]; [@bib1]). Foxp3 plays an essential role in the suppressive function of T~reg~ cells ([@bib39]), and Foxp3 deficiency causes a multiorgan autoimmune disease as can be observed in the scurfy mouse and in patients with IPEX (immunodysregulation polyendocrinopathy enteropathy X-linked syndrome; [@bib2]; [@bib3]; [@bib4]). Foxp3 induction in natural T~reg~ cells (nT~reg~ cells) occurs in vivo during thymic differentiation, under the influence of relatively high avidity interactions of the TCR with self-antigens.

Although the suppression of autoimmunity by T~reg~ cells is now well established, recently, nT~reg~ cells have been shown to convert to effector/helper T cells ([@bib18]). Although most T~reg~ cells retain high Foxp3 expression after adoptive transfer to a nonpathogenic setting, 10--15% of T~reg~ cells were found to lose Foxp3 expression after adoptive transfer into lymphopenic hosts. A recent study showed that half of T~reg~ cells transferred into lymphopenic hosts did not die, but rather began producing IL-2 and IFN-γ ([@bib18]). Additionally, multiple recent studies have demonstrated that in the inflammatory settings of autoimmunity, there is a loss of Foxp3 during inflammatory responses ([@bib47]; [@bib22]). The adoptive transfer of T~reg~ cells into *Cd3ε^−/−^* hosts, which retain B lymphocytes, resulted in the loss of Foxp3 expression and the generation of lapsed T~reg~ cells that differentiated into follicular helper T cells in Peyer's patches that promoted IgA class switching ([@bib38]). Such exFoxp3 cells ([@bib47]) or lapsed T~reg~ cells ([@bib22]) develop an effector-memory phenotype, produce pathogenic cytokines, and can trigger the development of autoimmunity. Two possibilities were proposed regarding the developmental plasticity of T~reg~ cells: (1) the lineage reprogramming of the conversion of committed Foxp3^+^ cells to Foxp3^−^ cells or (2) the expansion of uncommitted T~reg~ cells, which easily lose Foxp3 ([@bib11]). In any case, the molecular basis for such T~reg~ cell conversion and the signals that ensure the stability of T~reg~ cells have not yet been clarified. On the contrary, recent work by [@bib26] reported that highly purified T~reg~ cells were very stable under physiological and inflammatory conditions. Such clarification is also necessary for the development of applications for transferring T~reg~ cells to treat autoimmune diseases or to prevent rejections of transplantations.

SOCS1 (suppressor of cytokine signaling 1) is apparently defined as an important mechanism for the negative regulation of the cytokine--JAK--STAT pathway ([@bib44]), and uncontrolled IFN-γ signaling results from a deficiency of SOCS1. SOCS1 is highly expressed in T~reg~ cells ([@bib19]). It has been reported that SOCS1 expression is reduced in lupus-affected (NZB × NZW) F1 mice ([@bib31]), and expression levels of SOCS1 are altered in patients with rheumatoid arthritis or systemic lupus erythematosus ([@bib14]; [@bib5]). Analyses of T cell--specific *Socs1* conditional KO (cKO; *Lck*Cre-*Socs1^f/f^*) mice revealed that SOCS1-deficient effector T cells produce high levels of IFN-γ and low levels of IL-17A (IL-17; [@bib36]). Although we have shown that the number of Foxp3-positive T~reg~ cells in cKO mice is higher than that in WT mice ([@bib19]), SOCS1-deficient T~reg~ cells lost proper suppression functions in T~reg~ cell--specific *Socs1*-cKO mice ([@bib20]). However, detailed mechanisms for the impaired T~reg~ cell function by SOCS1 deficiency remain to be clarified.

This study was undertaken to clarify the role of SOCS1 in the stability and suppressive function of T~reg~ cells. We observed autoimmune phenotypes in T cell--specific *Socs1*-cKO mice, suggesting a defective T~reg~ cell function in these mice. The defective suppression activity of SOCS1-deficient T~reg~ cells was confirmed through the failure to suppress colitis in *Rag2^−/−^* mice by the cotransfer of naive T cells and T~reg~ cells. In lymphopenic conditions, *Socs1^−/−^* T~reg~ cells tended to lose Foxp3 and were easily converted into Th1-like IFN-γ--producing cells. Foxp3 levels were preserved in *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells, yet *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells could still not suppress colitis induced by the transfer of naive T cells. To our surprise, *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells produced extremely high levels of IL-17, thereby instructing Th17 cell differentiation of naive T cells in *Rag2^−/−^* mice. *Il-17^−/−^* naive T cells still caused colitis but were suppressed by the cotransfer of *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells, which suggests that *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells instruct naive T cells to become colitogenic by producing high levels of IL-17. In vitro experiments suggest that cytokines from *Socs1^−/−^* T~reg~ cells play roles in the instruction of Th1 and Th17 through APCs. We propose that SOCS1 is a guardian of T~reg~ cells because SOCS1 inhibits the conversion of T~reg~ cells into Th1- and Th17-like IFN-γ-- and IL-17--producing cells.

RESULTS
=======

Autoimmune phenotypes caused by *Lck*Cre-*Socs1^f/f^* mice and impaired suppression activity of SOCS1-deficient nT~reg~ cells in vivo
-------------------------------------------------------------------------------------------------------------------------------------

As reported previously, T cell--specific *Socs1*-deleted (*Lck*Cre-*Socs1^f/f^*; cKO) mice survived \>6 mo ([@bib36]), yet all of these mice eventually developed dermatitis, splenomegaly, and lymphadenopathy with age ([Fig. 1, A--C](#fig1){ref-type="fig"}). Inflammatory cellular infiltrations in the skin, liver, and kidney were observed in these mice ([Fig. 1 D](#fig1){ref-type="fig"}). Serum Ig levels were much higher in cKO mice than in *Socs1^f/f^* (WT) mice, and dsDNA antibodies were detected as well ([Fig. 1 E](#fig1){ref-type="fig"}). These data suggest that cKO mice developed a systemic inflammatory and autoimmune disease.

![**Characterization of *Lck*Cre-*Socs1^f/f^* (cKO) mice.** (A) Representative appearance of a 12-wk-old cKO mouse. (B) Incidence of dermatitis in cKO mice (*n* = 20). (C) Representative macroscopic view of the spleen and LN of a *Socs1^f/f^* (WT) mouse and its age (12 wk old)- and sex-matched cKO counterpart. (D) Representative histopathology of the skin, liver, and kidneys of a WT mouse and its age (12 wk old)- and sex-matched cKO counterpart. Data are representative of five independent experiments. Bars, 200 µm. (E and F) Serum titers of Ig subclasses and anti-dsDNA antibodies (E) and serum levels of IFN-γ (F) from WT and cKO mice measured by ELISA. Each symbol indicates individual host mouse (\*, P \< 0.05). Data are representative of seven independent experiments. Horizontal bars indicate the mean. (G) Representative Foxp3-GFP expression on CD3^+^CD4^+^ T cells from the thymus of WT and cKO mice as determined by flow cytometry.](JEM_20110428_RGB_Fig1){#fig1}

The autoimmune phenotype of T cell--specific *Socs1*-cKO mice has been thought to be mostly caused by hyperactivation of effector T cells and the production of a huge amount of IFN-γ ([Fig. 1 F](#fig1){ref-type="fig"}). Because *Ifnγ^−/−^Lck*Cre-*Socs1^f/f^* mice did not develop dermatitis (not depicted), these phenotypes were dependent on IFN-γ. cKO mice and *Socs1^f/f^* littermates were crossed with knockin mice with Foxp3-IRES-GFP as reported previously ([@bib40]), and the number of nT~reg~ cells was increased in cKO-*Foxp3^GFP^* mice in the thymus ([Fig. 1 G](#fig1){ref-type="fig"}) and periphery ([@bib45]). Similar autoimmune phenotypes were observed in T~reg~ cell--specific *Socs1*-deleted mice, *Foxp3*Cre-*Socs1^f/f^* mice ([@bib20]), suggesting that SOCS1-deficient nT~reg~ cells have a defective suppression activity.

The defective suppression activity of SOCS1-deficient T~reg~ cells in vivo was confirmed by the failure to suppress colitis in *Rag2^−/−^* mice by the cotransfer of naive T cells (Ly5.1) and T~reg~ cells (Ly5.2; [Fig. 2 A](#fig2){ref-type="fig"} and [Fig. S1](http://www.jem.org/cgi/content/full/jem.20110428/DC1)). T~reg~ cells were purified by FACS sorting as CD3^+^CD4^+^CD25^+^GFP^+^ (\>99% Foxp3 positive). 4 wk after transfer, the fraction of Foxp3-positive cells from Ly5.2-positive cKO-*Foxp3^GFP^* mice was significantly decreased compared with those from Ly5.2-positive WT-*Foxp3^GFP^* mice ([Fig. 2 B](#fig2){ref-type="fig"}). IFN-γ levels in the mesenteric LN in *Rag2^−/−^* mice cotransferred with naive T cells and *Socs1^−/−^* T~reg~ cells were much higher than in *Rag2^−/−^* mice transferred with naive T cells and WT T~reg~ cells (not depicted). These results indicate that the suppressive function of SOCS1-deficient T~reg~ cells was impaired in lymphopenic conditions, concomitant with faster loss of Foxp3 expression, compared with that of WT T~reg~ cells.

![**SOCS1-deficient T~reg~ cells have attenuated suppressive function, lose Foxp3 expression, and produce effector cytokines.** (A and B) 2 × 10^5^ T~reg~ cells from the LN of Ly5.2 WT-*Foxp3^GFP^* mice (*Socs1^+/+^* T~reg~ cells) or Ly5.2 cKO-*Foxp3^GFP^* mice (*Socs1^−/−^* T~reg~ cells) were cotransferred with 4 × 10^5^ Ly5.1 naive T cells into *Rag2^−/−^* mice. 4 wk later, recipient mice were analyzed. (A) Body weight changes. (B) Flow cytometric analysis of Foxp3-GFP expression on Ly5.2^+^CD3^+^CD4^+^ T cells from the LN in *Rag2^−/−^* mice (percentage of Foxp3-GFP^+^ shown in bar graph). (C--G) 2 × 10^5^ *Socs1^+/+^* or *Socs1^−/−^* Foxp3^+^ T~reg~ cells were transferred into *Rag2^−/−^* mice. 6 wk after transfer, recipient mice were analyzed. (C) Body weight changes. (D) Flow cytometric analysis of Foxp3-GFP expression on CD3^+^CD4^+^ T cells from the LN in *Rag2^−/−^* mice (percentage of Foxp3-GFP^+^ indicated in bar graph). (E) Expression profiles of CD25 and intracellular CTLA4 on CD3^+^CD4^+^GFP^+^ cells and GFP^−^ cells from the LN in *Rag2^−/−^* mice (right) compared with those on CD3^+^CD4^+^GFP^+^ cells before transfer (left; mean fluorescent intensity \[MFI\], bottom). (F) Flow cytometric analysis of Foxp3-GFP and IFN-γ expression on CD3^+^CD4^+^cells from the LN in *Rag2^−/−^* mice (percentage of IFN-γ^+^ shown in bar graph below). (G) Expression of IFN-γ and IL-2 on CD3^+^CD4^+^GFP^+^ cells from the LN in *Rag2^−/−^* mice (percentage of IL-2-- and IFN-γ--producing cells indicated in bar graph). (A--G) Data are representative of three independent experiments (\*, P \< 0.05; \*\*, P \< 0.01). Values represent the mean ± SD.](JEM_20110428_RGB_Fig2){#fig2}

Loss of Foxp3 expression and conversion to Th1-like cells of SOCS1-deficient T~reg~ cells in lymphopenic conditions
-------------------------------------------------------------------------------------------------------------------

We then investigated the fate of Foxp3^+^ cells in lymphopenic conditions. T~reg~ cells from WT-*Foxp3^GFP^* or cKO-*Foxp3^GFP^* mice were transferred into *Rag2^−/−^* mice, and 6 wk later, Foxp3 positivity was examined by flow cytometry. WT T~reg~ cells lost Foxp3 expression in the single-transfer condition more significantly than in the cotransfer with naive T cells, yet they did not develop colitis, as shown previously ([@bib18]). Surprisingly, SOCS1-deficient T~reg~ cells transferred into *Rag2^−/−^* mice developed colitis ([Fig. 2 C](#fig2){ref-type="fig"} and [Fig. S2](http://www.jem.org/cgi/content/full/jem.20110428/DC1)). SOCS1-deficient T~reg~ cells experienced a more profound loss than did WT T~reg~ cells (63.1% Foxp3^+^ in WT T~reg~ cells vs. 40.7% in SOCS1-deficient T~reg~ cells; [Fig. 2 D](#fig2){ref-type="fig"}).

Not only Foxp3 but also other phenotypical markers of T~reg~ cells, CD25 and CTLA4, which have been shown to be critical molecules in the suppression activity of T~reg~ cells ([@bib41]), were altered in transferred SOCS1-deficient T~reg~ cells. Before transfer, SOCS1-deficient T~reg~ cells expressed CD25 and CTLA4 at significantly higher levels than did WT T~reg~ cells. After transfer, however, CD25 and CTLA4 were more profoundly down-regulated in *Socs1^−/−^* T~reg~ cells than in WT T~reg~ cells, in both the Foxp3-maintaining fraction (Foxp3^+→+^; [Fig. 2 E](#fig2){ref-type="fig"}) and the exFoxp3 fraction (Foxp3^+→−^; [Fig. 2 E](#fig2){ref-type="fig"}, top and bottom). In addition, transferred *Socs1^−/−^* T~reg~ cells produced higher amounts of IFN-γ from both the Foxp3-maintaining and the Foxp3-losing fractions ([Fig. 2 F](#fig2){ref-type="fig"}, top and bottom). The Foxp3-maintaining fraction of SOCS1-deficient Foxp3^+^ T~reg~ cells also produced IL-2 in addition to IFN-γ ([Fig. 2 G](#fig2){ref-type="fig"}, top and bottom). These results indicate that SOCS1-deficient T~reg~ cells tend to lose Foxp3 expression and produce effector cytokines, thus suggesting that SOCS1 is necessary for preventing IFN-γ--producing exFoxp3 cell development.

To exclude the possibility that the higher number of Foxp3^−^ cells in Foxp3^+^*Socs1^−/−^* T~reg~ cell transfer was caused by an extraordinary expansion of contaminated Foxp3^−^*Socs1^−/−^* cells, activated/memory *Socs1^−/−^* or *Socs1^+/+^* T cells (Ly5.2^+^CD44^high^CD62L^−^Foxp3^−^ cells) were mixed to 3.3% in the cotransfer of Ly5.1 WT naive T cells and T~reg~ cells ([Fig. S3](http://www.jem.org/cgi/content/full/jem.20110428/DC1), top) or to 5% in the transfer of Ly5.1 WT T~reg~ cells into *Rag2^−/−^* mice (Fig. S3, bottom). Any abnormal expansion of activated/memory *Socs1^−/−^* T cells was not observed, suggesting that the larger number of Foxp3^−^ cells in *Socs1^−/−^* T~reg~ cell transfer was not caused by rapid expansion of contaminated SOCS1-deficient Foxp3^−^ T cells.

IL-10 from T~reg~ cells has been shown to play an important role in the suppression of naive T cell--induced colitis in *Rag2^−/−^* mice ([@bib21]). Thus, we suspected that impaired IL-10 production from SOCS1-deficient T~reg~ cells could be a mechanism for SOCS1-deficient T~reg~ cell--mediated colitis. However, production of IL-10 was significantly higher in *Socs1^−/−^* T~reg~ cells compared with WT T~reg~ cells both before and after transfer, suggesting that IL-10 is not involved in the SOCS1-deficient T~reg~ cell--mediated colitis ([Fig. S4](http://www.jem.org/cgi/content/full/jem.20110428/DC1)).

Rapid methylation of the CNS2 (conserved noncoding DNA sequence 2) region in the Foxp3 enhancer of committed SOCS1-deficient T~reg~ cells
-----------------------------------------------------------------------------------------------------------------------------------------

Like in *Rag2^−/−^* mice, Foxp3 levels were decreased more rapidly in *Socs1^−/−^* T~reg~ cells than in WT T~reg~ cells in vitro. CFSE dilution revealed that the loss of Foxp3 occurred mostly in divided T~reg~ cells, suggesting that the loss of Foxp3 is associated with cell division or that cells that lost Foxp3 expression divide faster than Foxp3^+^ cells ([Fig. 3 A](#fig3){ref-type="fig"}). It has been reported that CD4^+^CD25^+^CD62L^high^ T~reg~ cells maintained stable Foxp3 expression along with suppressive activity after in vitro expansion compared with CD4^+^CD25^+^CD62L^low^ T~reg~ cells ([@bib30]). Thus, we compared Foxp3 expression levels in *Socs1^+/+^* and *Socs1^−/−^* T~reg~ cells between the CD62^high^ and CD62L^low^ fraction after 3-d in vitro culture. The fraction of CD62L^low^ was much higher than that of CD62L^high^ in *Socs1^−/−^* T~reg~ cells ([Fig. 3 B](#fig3){ref-type="fig"}). As reported, Foxp3 expression was decreased in the CD62L^low^ fraction in WT T~reg~ cells, and Foxp3 was maintained in the CD62L^high^ fraction ([Fig. 3 C](#fig3){ref-type="fig"}, left). In *Socs1^−/−^* T~reg~ cells, Foxp3 was also maintained in the CD62L^high^ fraction. However, the loss of Foxp3 expression in the CD62L^low^ fraction was significantly more drastic in *Socs1^−/−^* T~reg~ cells than in WT T~reg~ cells ([Fig. 3 C](#fig3){ref-type="fig"}, right).

![**Foxp3 loss in SOCS1-deficient T~reg~ cells is associated with cell division and methylation of the CNS2 region.** (A) Flow cytometric analysis of Foxp3 expression in *Socs1^+/+^* and *Socs1^−/−^* T~reg~ cells cultured for 3 d. Numbers on flow plots indicate the percentage of divided cells in each group (left). Each fraction was analyzed for Foxp3 staining (right). (B) Flow cytometric analysis of CD62L and CD44 expression on CD3^+^CD4^+^ T cells (left) and CD3^+^CD4^+^GFP^+^ T cells (right) from the LN of cKO mice and WT littermate controls. (C) Flow cytometric analysis of Foxp3-GFP expression on CD62L^high^ and CD62L^low^ CD3^+^CD4^+^ T cells after 3-d in vitro culture (percentage of Foxp3-GFP^+^ indicated in bar graph). Data are representative of three independent experiments (\*\*\*, P \< 0.0001). Values represent the mean ± SD. (D and E) Bisulfite sequencing of genomic DNA from WT naive T cells and T~reg~ cells from the LN of WT-*Foxp3^GFP^* and cKO-*Foxp3^GFP^* male mice. (D) Methylation status of the CNS2 region. After Foxp3^+^ T~reg~ cells were cultured in vitro for 3 d, Foxp3^+^ and Foxp3^−^ cells were sorted. 10 CpG methylation sites in the CNS2 region of the Foxp3 gene were analyzed before culture (left) and after 3-d in vitro culture (middle and right). Foxp3-maintained cells (Foxp3^+→+^; middle) and Foxp3-lost cells (Foxp3^+→−^; right) are shown. (E) Methylation status of the CNS2 region 4 wk after transfer of Foxp3^+^ T~reg~ cells into *Rag2^−/−^* mice. Before transfer (left), Foxp3-maintained cells (Foxp3^+→+^; middle), and Foxp3-lost cells (Foxp3^+→−^; right) are shown. Percentages of clones displaying each methylation status of CpG methylation sites are indicated in sector graphs. 10--15 clones were sequenced from each subset.](JEM_20110428_RGB_Fig3){#fig3}

Recently, it has been reported that the DNA methylation status of the CNS2 region in the Foxp3 enhancer is particularly important for maintenance of Foxp3 expression ([@bib8]; [@bib15]; [@bib46]). To examine whether SOCS1-deficient Foxp3^+^ T~reg~ cells contained uncommitted T~reg~ cells or unstable inducible T~reg~ cells (iT~reg~ cells), we determined the methylation status of the CNS2 region in SOCS1-deficient T~reg~ cells. As shown in [Fig. 3 D](#fig3){ref-type="fig"}, the CNS2 region of T~reg~ cells from the LN of SOCS1-cKO mice were fully demethylated, similar to those of WT mice ([Fig. 3 D](#fig3){ref-type="fig"}). This indicates that \>95% SOCS1-deficient T~reg~ cells were committed and did not contain iT~reg~ cells. After 3-d in vitro culture, the Foxp3-maintaining fraction (Foxp3^+→+^) retained full demethylation in the CNS2 region in both *Socs1^+/+^* and *Socs1^−/−^* T~reg~ cells. However, the CNS2 region in the exFoxp3 fraction (Foxp3^+→−^) was fully or partially methylated, and more methylation occurred in the SOCS1-defcient exFoxp3 cells than in the SOCS1-sufficient exFoxp3 cells ([Fig. 3 D](#fig3){ref-type="fig"}), which is consistent with a more rapid loss of Foxp3 in *Socs1^−/−^* T~reg~ cells than in WT T~reg~ cells.

In vivo, we also found hypermethylation of the CNS2 region in Foxp3^−^ cells after transfer of Foxp3^+^ cells into *Rag2^−/−^* mice ([Fig. 3 E](#fig3){ref-type="fig"}). More intensive hypermethylation in the CNS2 region in Foxp3^−^ cells was observed in *Socs1^−/−^* T~reg~ cell transfer than in WT T~reg~ cell transfer ([Fig. 3 E](#fig3){ref-type="fig"}; \>90% methylated regions were 90% in *Socs1^−/−^* vs. 50% in *Socs1^+/+^*). Thus, the CNS2 region of the *Foxp3* gene in exFoxp3 cells from SOCS1-deficient T~reg~ cells was more easily hypermethylated not only in vitro but also in vivo than that from WT T~reg~ cells ([Fig. 3 E](#fig3){ref-type="fig"}).

Accelerated conversion of SOCS1-deficient T~reg~ cells into Th1- and Th17-like cells in vitro
---------------------------------------------------------------------------------------------

It has been reported that T~reg~ cells convert into Th1- or Th17-like cells in appropriate in vitro culture conditions ([@bib42]). To investigate the mechanism of the loss of Foxp3 and enhanced IFN-γ production from *Socs1^−/−^* T~reg~ cells in vivo, we performed an in vitro conversion assay. As shown in [Fig. 4 A](#fig4){ref-type="fig"}, when Foxp3^+^ cells were cultured in the presence of TCR stimulation and IL-2, much higher amounts of IFN-γ as well as of IL-17 were produced from *Socs1^−/−^* T~reg~ cells than from WT T~reg~ cells. IL-12 further up-regulated IFN-γ production, whereas IL-17 was up-regulated by IL-1 and IL-6 ([Fig. 4 A](#fig4){ref-type="fig"}). Interestingly, the production of IL-17 by IL-1 and IL-6 was dependent on TGF-β because anti--TGF-β antibody abrogated the effect of IL-1 and IL-6.

![**SOCS1-deficient T~reg~ cells convert into Th1- and Th17-like cells in vitro.** (A) 10^5^ *Socs1^+/+^* and *Socs1^−/−^* T~reg~ cells/well were activated with anti-CD3/anti-CD28 beads, 10 ng/ml IL-2, and the indicated cytokines, and IFN-γ and IL-17A were measured by ELISA (\*\*\*, P \< 0.0001). (B) Detection of phosphorylations of STAT1 and STAT3 in T~reg~ cells with the indicated genotypes by immunoblot (left) and flow cytometry (right; mean fluorescent intensity is indicated in the bar graph; \*, P \< 0.05; \*\*, P \< 0.01). (A and B) Data are representative of five independent experiments. Values represent the mean ± SD.](JEM_20110428_RGB_Fig4){#fig4}

Because SOCS1 has been shown to be an essential negative regulator for the JAK--STAT pathway, the activation status of STAT1 and STAT3 were compared using immunoblotting and intracellular staining ([Fig. 4 B](#fig4){ref-type="fig"}). STAT5 was reported to be phosphorylated in SOCS1-deficient T~reg~ cells at higher levels than in WT T~reg~ cells, which is associated with the increase in the number of T~reg~ cells ([@bib19]). Much stronger tyrosine phosphorylation of both STAT1 and STAT3 were observed in freshly isolated SOCS1-deficient T~reg~ cells than in WT T~reg~ cells by both methods ([Fig. 4 B](#fig4){ref-type="fig"}). These data indicate that SOCS1 is necessary for the suppression of spontaneous activation of STAT1 and STAT3 in T~reg~ cells.

Foxp3 was stabilized in *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells
----------------------------------------------------------

Because SOCS1 is a strong inhibitor for the IFN-γ--STAT1 pathway, we hypothesized that hyper-STAT1 activation led to abnormalities in SOCS1-deficient T~reg~ cells. To address this hypothesis, we used T~reg~ cells from *Ifnγ^−/−^Socs1^−/−^* mice.

Most of the *Ifnγ^−/−^Socs1^+/+^* and *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells (CD4^+^CD25^bright^ fraction) were CD62L^high^ and CD44^high^, suggesting that IFN-γ deficiency diminished CD62L^low^ T~reg~ cell subsets ([Fig. 5 A](#fig5){ref-type="fig"}). Consistently, when T~reg~ cells from both *Ifnγ^−/−^Socs1^+/+^* and *Ifnγ^−/−^Socs1^−/−^* mice were transferred into *Rag2^−/−^* mice, colitis did not develop even 6 wk after transfer ([Fig. 5 B](#fig5){ref-type="fig"}). Foxp3 expression in *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells was as stable as in *Ifnγ^−/−^Socs1^+/+^* T~reg~ cells and WT T~reg~ cells after transfer into *Rag2^−/−^* mice ([Figs. 2 D](#fig2){ref-type="fig"} and [5 C](#fig5){ref-type="fig"}). After transfer, unlike in *Socs1^−/−^* T~reg~ cells, CD25 and CTLA4 were maintained at significantly higher levels in *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells ([Fig. 5 D](#fig5){ref-type="fig"}, top and bottom). We examined the methylation status of the CNS2 region in both *Ifnγ^−/−^Socs1^+/+^* and *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells in vitro. The CNS2 region of T~reg~ cells from the LN of *Ifnγ^−/−^Socs1^+/+^* and *Ifnγ^−/−^Socs1^−/−^* mice were fully demethylated ([Fig. 5 E](#fig5){ref-type="fig"}). After 3-d culture, the Foxp3-maintaining fraction (Foxp3^+→+^) retained full demethylation in the CNS2 region in both *Ifnγ^−/−^Socs1^+/+^* and *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells. Methylation levels of the CNS2 region in the *Ifnγ^−/−^* exFoxp3 fraction (Foxp3^+→−^) were lower than those in the *Ifnγ^+/+^* exFoxp3 fraction ([Figs. 3 D](#fig3){ref-type="fig"} and [5 E](#fig5){ref-type="fig"}), suggesting that IFN-γ played a positive role in the methylation of the CNS2 region in T~reg~ cells. The rate of methylation in the CNS2 region in *Ifnγ^−/−^Socs1^−/−^* exFoxp3 cells was lower than that in *Ifnγ^−/−^Socs1^+/+^* exFoxp3 cells. These results were consistent with a stable Foxp3 expression in *Ifnγ^−/−^Socs1^+/+^* and *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells after transfer into *Rag2^−/−^* mice.

![**IFN-γ suppresses CNS2 methylation and Foxp3 loss in SOCS1-deficient T~reg~ cells.** (A) Expression profiles of CD62L and CD44 on CD3^+^CD4^+^CD25^bright^ cells of the LN cells from *Ifnγ^−/−^Socs1^+/+^* and *Ifnγ^−/−^Socs1^−/−^* mice. (B--D) 2 × 10^5^ T~reg~ cells from *Ifnγ^−/−^Socs1^+/+^* mice or *Ifnγ^−/−^Socs1^−/−^* mice were transferred into *Rag2^−/−^* mice. 6 wk after transfer, recipient mice were analyzed. (B) Body weight changes. (C) Flow cytometric analysis of Foxp3 expression on CD3^+^CD4^+^ T cells from the LN in *Rag2^−/−^* mice (percentage of Foxp3^+^ indicated in bar graph). (D) CD25 and intracellular CTLA4 expression on CD3^+^CD4^+^Foxp3^+^ cells and Foxp3^−^ cells from the LN in *Rag2^−/−^* mice (right) compared with those on CD3^+^CD4^+^CD25^bright^ cells before transfer (left; mean fluorescent intensity \[MFI\] indicated in bar graph). Data are representative of three independent experiments (\*, P \< 0.05; \*\*, P \< 0.01). Values represent the mean ± SD. (E) Bisulfite sequencing of genomic DNA from T~reg~ cells from the LN of *Ifnγ^−/−^Socs1^+/+^* and *Ifnγ^−/−^Socs1^−/−^* male mice. 10 CpG methylation sites in the CNS2 region of the Foxp3 gene were analyzed before culture (left) and after 3-d in vitro culture. Percentages of clones displaying each methylation status of CpG methylation sites are indicated in sector graphs. 10--15 clones were sequenced from each subset.](JEM_20110428_RGB_Fig5){#fig5}

*Ifnγ^−/−^Socs1^−/−^* T~reg~ cells still lacked in vivo suppression activity because of stronger Th17 instruction
-----------------------------------------------------------------------------------------------------------------

To test the suppression activity, T~reg~ cells from *Ifnγ^−/−^Socs1^+/+^* or *Ifnγ^−/−^Socs1^−/−^* mice were then transferred into *Rag2^−/−^* mice with naive T cells. 4 wk after transfer, T~reg~ cells from *Ifnγ^−/−^Socs1^+/+^* mice suppressed colitis elicited by naive T cells ([Fig. 6 A](#fig6){ref-type="fig"} and [Fig. S7](http://www.jem.org/cgi/content/full/jem.20110428/DC1)). The suppression activity of *Ifnγ^−/−^* T~reg~ cells was lower than that of *Ifnγ^+/+^* T~reg~ cells ([Figs. 2 A](#fig2){ref-type="fig"} and [6 A](#fig6){ref-type="fig"}), yet recipient mice did not develop severe colitis 4 wk after T cell transfer. To our surprise, *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells could not prevent colitis, which was confirmed by body weight loss and histological examination ([Fig. 6 A](#fig6){ref-type="fig"} and [Fig. S5](http://www.jem.org/cgi/content/full/jem.20110428/DC1)). Expression of Foxp3 in *Ifnγ^−/−^Socs1^+/+^* T~reg~ cells as well as in *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells was maintained in recipient *Rag2^−/−^* mice ([Fig. 6 B](#fig6){ref-type="fig"}), just as it was in the transfer of T~reg~ cells alone ([Fig. 2 B](#fig2){ref-type="fig"}). Therefore, Foxp3 maintenance is not sufficient for the suppression of effector T cell functions in vivo.

![***Ifnγ^−/−^Socs1^−/−^* T~reg~ cells fail to suppress colitis in vivo.** (A and B) 2 × 10^5^ Ly5.2 *Ifnγ^−/−^Socs1^+/+^* or Ly5.2 *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells were cotransferred with 4 × 10^5^ Ly5.1 naive T cells into *Rag2^−/−^* mice. 4 wk after transfer, recipient *Rag2^−/−^* mice were analyzed. (A) Body weight changes. (B) Flow cytometric analysis of Foxp3 expression on Ly5.2^+^CD3^+^CD4^+^ T cells from the LN in *Rag2^−/−^* mice (percentage of Foxp3^+^ indicated in bar graph). (C) Flow cytometric analysis of IFN-γ and IL-17A on Ly5.1^+^CD3^+^CD4^+^cells (top) and Ly5.2^+^CD3^+^CD4^+^ T cells (middle) from the LN in recipient mice (percent positivity, bottom). (A--C) Data are representative of three independent experiments (\*, P \< 0.05; \*\*, P \< 0.01). Values represent the mean ± SD.](JEM_20110428_RGB_Fig6){#fig6}

To understand these unexpected results, we examined the production of inflammatory cytokines from T~reg~ cells or naive/effector cells transferred into *Rag2^−/−^* mice. IL-10 levels were not significantly different between *Ifnγ^−/−^Socs1^+/+^* and *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells (Fig. S4). Because Th17 has also been implicated in colitis ([@bib6]; [@bib7]), we then compared IFN-γ and IL-17 production from naive/effector (Ly5.1^+^) T cells ([Fig. 6 C](#fig6){ref-type="fig"}, top) and T~reg~ cells (Ly5.1^−^, Ly5.2^+^; [Fig. 6 C](#fig6){ref-type="fig"}, middle) in the LN of transferred recipient mice, after which percent positivity values of cytokine production were determined by flow cytometry ([Fig. 6 C](#fig6){ref-type="fig"}, bottom). As shown in [Fig. 6 C](#fig6){ref-type="fig"}, when naive T cells alone were transferred into *Rag2^−/−^* mice, a portion of these cells converted into effector cells that produced mainly IFN-γ, but with very low levels of IL-17 ([Fig. 6 C](#fig6){ref-type="fig"}, a). When naive T cells and WT T~reg~ cells were cotransferred, differentiation of Th1-like cells from naive T cells was completely suppressed ([Fig. 6 C](#fig6){ref-type="fig"}, b). However, when naive T cells and *Socs1^−/−^* T~reg~ cells were cotransferred, both IFN-γ-- and IL-17--producing cells appeared from transferred naive T cells, which is consistent with the failure of suppression of colitis by *Socs1^−/−^* T~reg~ cells ([Fig. 6 C](#fig6){ref-type="fig"}, c). Thus, SOCS1-deficient T~reg~ cells promoted Th1 and Th17 cell differentiation from naive T cells, whereas WT T~reg~ cells did not. In contrast, when naive T cells and *Ifnγ^−/−^Socs1^+/+^* T~reg~ cells were cotransferred, a significant fraction of IL-17--producing cells appeared from transferred naive T cells ([Fig. 6 C](#fig6){ref-type="fig"}, d). IL-17 was also produced from transferred T~reg~ cells. These results could explain why *Ifnγ^−/−^* T~reg~ cells did not prevent colitis very efficiently ([Fig. 6 A](#fig6){ref-type="fig"}). Much more intense IL-17 production was observed from both naive T cells and T~reg~ cell fractions in recipient mice cotransferred with naive T cells and *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells ([Fig. 6 C](#fig6){ref-type="fig"}, e). These data suggest that the cytokine profile of T~reg~ cells instructs the direction of differentiation of Th1 or Th17 from naive T cells in lymphopenic conditions.

Instruction of Th1 and Th17 cell differentiation by cytokines from T~reg~ cells through APCs in vitro
-----------------------------------------------------------------------------------------------------

To confirm these instructions by T~reg~ cells, we first measured IL-17 from IFN-γ--deficient T~reg~ cells in in vitro culture experiments. As expected, *Ifnγ^−/−^* T~reg~ cells produced higher amounts of IL-17 than did WT T~reg~ cells, and IL-17 production was further enhanced by SOCS1 deficiency ([Fig. 7 A](#fig7){ref-type="fig"}). These data suggest that IFN-γ usually suppressed IL-17 production from T~reg~ cells, which skewed Th1 cell differentiation from naive T cells. Coincidently, hyper-STAT1 activation was not observed in *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells, although STAT3 activation was still high ([Fig. 7 B](#fig7){ref-type="fig"}, top and bottom). Thus, hyper STAT3 activation could account for high levels of IL-17 production from *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells.

![**exFoxp3 cells instruct differentiation of naive T cells to Th1 and Th17 in vitro.** (A) 10^5^ *Socs1^+/+^*, *Ifnγ^−/−^Socs1^+/+^*, or *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells/well were stimulated with anti-CD3/anti-CD28 beads, 10 ng/ml IL-2, and the indicated cytokines, and IL-17A was measured by ELISA. Data are representative of five independent experiments (\*\*\*, P \< 0.001). (B) Phosphorylation status of STAT1 and STAT3 in T~reg~ cells with the indicated genotypes by flow cytometry (mean fluorescent intensity shown in bar graph). Data are representative of five independent experiments (\*\*, P \< 0.01). (C) 3 × 10^5^ WT naive T cells/well were cultured for 5 d alone (top) or with untreated APCs (middle) or LPS-stimulated APCs (bottom ; 7 × 10^5^ T cell--depleted spleen cells/well) plus supernatants from *Socs1^+/+^*, *Socs1^−/−^*, or *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells (2 × 10^5^/well) cultured for 2 d in the presence of anti-CD3/anti-CD28 beads and 10 ng/ml IL-2. Flow cytometric analysis of IFN-γ and IL-17A on these cells is shown. Data are representative of three independent experiments. (D) 2 × 10^5^ *Socs1^+/+^*, *Socs1^−/−^*, *Ifnγ^−/−^Socs1^+/+^*, or *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells were cotransferred with 4 × 10^5^ *Il17^−/−^* naive T cells into *Rag2^−/−^* mice, and body weight is shown. Data are representative of three independent experiments (\*, P \< 0.05; \*\*, P \< 0.01). (A, B, and D) Values represent the mean ± SD.](JEM_20110428_RGB_Fig7){#fig7}

The effect of culture supernatants of T~reg~ cells on Th1/Th17 cell differentiation was then examined ([Fig. 7 C](#fig7){ref-type="fig"}). Culture supernatants of T~reg~ cells were added to the co-culture of naive T cells only or in the presence or absence of APCs ([Fig. 7 C](#fig7){ref-type="fig"}). In the absence of APCs, culture supernatants from *Socs1^+/+^* T~reg~ cells, *Socs1^−/−^* T~reg~ cells, or *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells did not promote Th1 or Th17 cell differentiation, suggesting that cytokines from T~reg~ cells modify the APCs for accelerated Th1 or Th17 cell differentiation form naive T cells ([Fig. 7 C](#fig7){ref-type="fig"}, top). Supernatants from *Socs1^−/−^* T~reg~ cells instructed naive T cells to differentiate into IL-17--producing effector cells when cultured with LPS-untreated APCs ([Fig. 7 C](#fig7){ref-type="fig"}, middle; and [Fig. S6, right](http://www.jem.org/cgi/content/full/jem.20110428/DC1)). This finding is consistent with our observations that *Socs1^−/−^* T~reg~ cells produced IL-17 ([Fig. 4 A](#fig4){ref-type="fig"}) and induced more Th17 in vivo ([Fig. 6 C](#fig6){ref-type="fig"}). This instruction of naive T cells was augmented by *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells, which produced the largest amount of IL-17 ([Fig. 7 A](#fig7){ref-type="fig"}), consistent with the results shown in [Fig. 6 C](#fig6){ref-type="fig"}. When APCs were activated by LPS ([Fig. 7 C](#fig7){ref-type="fig"}, bottom; and Fig. S6, left), naive T cells, after the addition of supernatant of *Socs1^−/−^* T~reg~ cells, were instructed to differentiate into IFN-γ--producing effector cells, which is again consistent with higher IFN-γ production from *Socs1^−/−^* T~reg~ cells ([Fig. 4 A](#fig4){ref-type="fig"}), and induced more Th1 in vivo ([Fig. 6 C](#fig6){ref-type="fig"}). *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells did not induce Th1 in LPS-treated APCs, suggesting that IFN-γ production from T~reg~ cells plays an important role in the Th1 instruction of naive T cells. Both IFN-γ and IL-17 antibodies abolished Th1 and Th17 instruction, respectively, confirming that IFN-γ and IL-17 from SOCS1-deficeint T~reg~ cells play essential roles in Th1 and Th17 induction from naive T cells (Fig. S6).

To confirm the role of APCs, we examined the effect of anticytokine antibodies on the in vitro instruction experiments (Fig. S6). Th1 instruction was eliminated by IL-12 antibodies, suggesting that IL-12 from APCs promoted Th1 cell differentiation. Consistent with this notion, *Socs1^−/−^* T~reg~ cells could not suppress colitis induced by *Ifnγr1^−/−^* naive T cells transferred into *Rag2^−/−^* mice (Fig. S7). This experiment suggested that IFN-γ from *Socs1^−/−^* T~reg~ cells still induced colitogenic T cells from *Ifnγr1^−/−^* naive T cells. In contrast, anti--IL-6 antibody completely inhibited and anti--TGF-β antibody partially inhibited Th17 instruction. Anti--IL-23 antibody did not affect Th17 cell differentiation. These results suggest that IL-17 from cultured T~reg~ cells stimulated IL-6 and TGF-β production from APCs, which promoted Th17 cell differentiation from naive T cells.

To confirm this possibility, we used IL-17--deficient naive T cells for the transfer. As shown in [Fig. 7 D](#fig7){ref-type="fig"}, *Rag2^−/−^* mice transferred with IL-17--deficient naive T cells developed colitis, which was less severe than in WT naive T cell transfer. However, *Socs1^−/−^* T~reg~ cells caused extremely severe colitis ([Fig. 7 D](#fig7){ref-type="fig"}), which was triggered by the large levels of IFN-γ (not depicted). As we expected, *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells as well as *Ifnγ^−/−^Socs1^+/+^* T~reg~ cells suppressed colitis induced by IL-17--deficient naive T cell transfer ([Fig. 7 D](#fig7){ref-type="fig"}). These data further support our hypothesis that *Ifnγ^−/−^* T~reg~ cells instruct Th17 cell differentiation of naive T cells, thereby suppressing colitis less efficiently, and these processes are accelerated when SOCS1 is deficient in *Ifnγ^−/−^* T~reg~ cells.

DISCUSSION
==========

In this study, we demonstrated that SOCS1 is necessary for T~reg~ stability and suppressor functions: SOCS1 protects T~reg~ cells from harmful effects of inflammatory cytokines, which promote the loss of Foxp3 expression and the conversion into Th1/Th17-like effector cells. Recent studies have shown that T~reg~ cells rapidly lose Foxp3 expression upon the transfer into a lymphopenic host ([@bib18]) or in inflammatory conditions ([@bib47]). Such exFoxp3 cells ([@bib47]) or lapsed T~reg~ cells ([@bib22]) develop an effector-memory phenotype, produce pathogenic cytokines, and can trigger the development of autoimmunity. Multiple studies have suggested that T~reg~ cells isolated from inflammatory sites express reduced amounts of Foxp3, possibly increasing susceptibility to autoimmunity ([@bib39]; [@bib37]).

Foxp3 expression is regulated by various factors, such as Smad2/3 ([@bib35]), Runx1 ([@bib16]; [@bib27]), STAT5 ([@bib43]), c-Rel ([@bib11]), and DNA methylation of the CNS2 region in the Foxp3 enhancer ([@bib46]). DNA methylation of CNS2 is particularly important because CNS2 is required for Foxp3 expression in the progeny of dividing T~reg~ cells ([@bib46]). Surprisingly, we found that the CNS2 region of freshly isolated SOCS1-deficient T~reg~ cells was fully demethylated, indicating that they are committed Foxp3^+^ T~reg~ cells. In *Rag2^−/−^* mice as well as in in vitro culture, part of the committed Foxp3^+^ cells expanded and converted into Foxp3^−^ cells (i.e., exFoxp3 cells). The CNS2 region in SOCS1-deficient exFoxp3 cells was more methylated than that in WT T~reg~ cells. Also, because the CNS2 methylation status of T~reg~ cells was altered after 3-d in vitro culture and there was a partially methylated CNS2 region, it is unlikely that all of the exFoxp3 cells were caused by the expansion of contaminated Foxp3^−^ effector T cells. Accordingly, we concluded that SOCS1 contributes to T~reg~ cell integrity by maintaining stable Foxp3 expression.

Our present study indicated that the excessive IFN-γ--STAT1 signals resulted in faster loss of Foxp3 expression in T~reg~ cells in lymphopenic conditions as well as in an in vitro culture system. One possibility is that the IFN-γ--STAT1 pathway increases reprogramming from SOCS1-deficient T~reg~ cells to effector cells. IFN-γ may promote the expansion or development of memory type CD62L^low^ cells because we observed that the CD62L^low^ fraction was at normal levels in IFN-γ/SOCS1 double-deficient T~reg~ cells. STAT1 may antagonize STAT5, yet this is unlikely because we could not observe the reduction of STAT5 phosphorylation in our SOCS1-deficient T~reg~ cells. STAT1 has also been shown to inhibit the TGF-β--Smad pathway ([@bib36]). The phenotypes of Smad2/3-deficient T~reg~ cells were similar to those observed in SOCS1-deficient T~reg~ cells ([@bib35]). Thus, the suppression of Smad signaling by STAT1 could be one of the mechanisms behind the reprogramming of T~reg~ cells. The relationship between these factors and the reprogramming of T~reg~ cells remain to be clarified.

Recently, [@bib26] reported that highly purified T~reg~ cells were very stable under physiological and inflammatory conditions. [@bib20] reported that Foxp3 expression of SOCS1-deficient T~reg~ cells from *Foxp3*Cre-*Socs1^f/f^* mice was maintained in the presence of naive and effector T cells, although the suppression activity of *Socs1^−/−^* T~reg~ cells was defective and IFN-γ was produced from *Socs1^−/−^* T~reg~ cells with STAT1 hyperactivation. Thus, Foxp3 expression in *Socs1^−/−^* T~reg~ cells from *Foxp3*Cre-*Socs1^f/f^* mice was more stable than that in *Socs1^−/−^* T~reg~ cells from *Lck*Cre-*Socs1^f/f^* mice. Because SOCS1 of *Lck*Cre-*Socs1^f/f^* mice is deleted in the T~reg~ cell progenitors, whereas SOCS1 of *Foxp3*Cre-*Socs1^f/f^* mice is deleted after T~reg~ cell maturation, this discrepancy may be explained by differences in the developmental conditions of T~reg~ cells. It is also possible that in *Lck*Cre-*Socs1^f/f^* mice, cytokines from *Socs1^−/−^* effector T cells could contribute to more drastic phenotypic changes in *Socs1^−/−^* T~reg~ cells.

A recent study has demonstrated that during lethal *Toxoplasma gondii* infection, the exposure of WT T~reg~ cells to high amounts of Th1 inflammatory mediators superimposes a Th1 effector program on T~reg~ cells of not only the Foxp3-losing portion but also the Foxp3-maintaining portion ([@bib24]). Thus, the conversion of T~reg~ cells to Th1 is one of the mechanisms for uncontrolled Th1 response in STAT1-hyperactivated T~reg~ cells, and this process is usually protected by SOCS1. Recently, [@bib20] reported on the defective suppression activity of SOCS1-deficient T~reg~ cells and IFN-γ production from these T~reg~ cells by STAT1 hyperactivation. In addition, our data suggest the intriguing possibility that hyperactivation of STAT3 in T~reg~ cells facilitates the conversion to Th17-like cells, which leads to an uncontrolled response in effector Th17 cells. STAT5, in contrast, enhances Foxp3 expression and the number of T~reg~ cells ([@bib19]).

Like STAT1, STAT3 has been reported to inhibit Foxp3 expression during iT~reg~/Th17 cell differentiation together with TGF-β ([@bib35]). However, the role of STAT3 in Foxp3 stability in T~reg~ cells seems to be more complicated. STAT3-deficient T~reg~ cells have been shown to expand less efficiently than WT T~reg~ cells in lymphopenic conditions ([@bib7]) and lose their suppression activity, especially for Th17 ([@bib6]; [@bib7]). Foxp3 was stable in *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells with hyperactivated STAT3. Thus, it is unlikely that the hyperactivation of STAT3 is linked to Foxp3 instability. Previously, we have shown that STAT3 activation is reduced in SOCS1-deficient naive T cells in response to IL-6 and TGF-β caused by SOCS3 induction ([@bib36]). The mechanism of hyperactivation of STAT3 in SOCS1-deficient T~reg~ cells remains to be investigated. Although Foxp3 expression of *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells is stabilized, these *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells were still defective in terms of the suppression of IL-17 production from both T~reg~ cells and effector T cells in *Rag2^−/−^* mice. This indicates that the stable expression of Foxp3 is not a sufficient condition for the suppression of effector Th17 cells. This may be linked to a high conversion potential of T~reg~ cells to Th17 cells. In a recent study using IL-17--RFP reporter mice with a Foxp3-GFP reporter, [@bib42] demonstrated the presence of a RFP^+^GFP^+^ transient phase upon T cell activation in vitro and in vivo. Thus, it is highly possible that both Th17 and T~reg~ cell programs could occur simultaneously in one cell, which underlies the conversion of Foxp3-positive T~reg~ cells to IL-17--producing cells. We observed that STAT3 was hyperactivated in *Socs1^−/−^* T~reg~ cells as well as in *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells. Although we do not have direct proof demonstrating that STAT3 hyperactivation is responsible for the conversion of T~reg~ cells to Th17, it is likely true because IL-17 production from nT~reg~ cells was enhanced by IL-6 and IL-1 and because STAT3, in addition to TGF-β signals, has been shown to be an essential factor for the generation of Th17.

SOCS1-deficient T~reg~ cells, which convert to Th1- and Th17-like cells, seem to instruct naive T cells to differentiate into the same cytokine-producing effector T cells. This can also explain why STAT1 or STAT3 hyperactivated T~reg~ cells cannot control Th1 or Th17 effectors, respectively. Intriguingly, previous studies have indicated that STAT1--T-bet ([@bib17]) and STAT3 ([@bib6]; [@bib7]) in T~reg~ cells are required for Th1 and Th17 suppression, respectively. Our current study, as well as a previous study ([@bib20]), clearly indicates that both the lack of STAT1/3 and unrestrained STAT1/3 activation in T~reg~ cells leads to a severe failure of immunological tolerance.

Anti--IFN-γ, --IL-17, --IL-12, and --IL-6 antibodies nearly completely inhibited Th1 and Th17 cell differentiation (Fig. S6). Thus, we clarified that IFN-γ from Th1-converted T~reg~ cells and IL-17 from Th17-converted T~reg~ cells preferentially induced effector Th1 and Th17 cell differentiation, respectively, by modulating APCs. It has been reported that T~reg~ cells interact with DCs before naive T cells and down-regulate the expression of CD80/86 caused by high levels of CTLA4 on T~reg~ cells ([@bib25]). Because SOCS1-deficient T~reg~ cells lose CTLA4 expression, they may not be able to suppress the expression levels of co-stimulator ligands. It has been reported that DCs treated with IFN-γ preferentially induce Th1 ([@bib10]), whereas IL-17--treated DCs preferentially induce Th17 cell differentiation because of the higher production of IL-1β, IL-6, and IL-23 from IL-17--treated DCs ([@bib33]). IL-17 may not directly induce Th17 cell differentiation in the absence of APCs because IL-17 has been reported to actually reduce Th17 cell differentiation ([@bib32]). These previous studies support our results, and IFN-γ and IL-17 from T~reg~ cells are thought to instruct effector T cell differentiation into Th1 or Th17 by modulating APCs.

In conclusion, we propose the idea that SOCS1 is an important guardian of T~reg~ cells. Our findings also raise the interesting possibility that up-regulation of SOCS1 in T~reg~ cells at appropriate levels reinforces T~reg~ cell functions because SOCS1 may protect T~reg~ cells from harmful effects of inflammatory cytokines that accelerate the conversion of T~reg~ cells into effectors. These findings may improve T~reg~ cell therapy for autoimmune diseases and organ transplantations.

MATERIALS AND METHODS
=====================

### Mice.

*Lck*Cre-*Socs1^f/f^* (T cell--specific *Socs1*-cKO; [@bib36]) and *Socs1^f/f^* (littermate control; WT) mice (sex and age matched) were used. cKO mice and *Socs1^f/f^* littermates crossed with knockin mice with Foxp3-IRES-GFP (WT-*Foxp3^GFP^* mice and cKO-*Foxp3^GFP^* mice) were provided by B. Malissen (Université de la Méditerranée, Marseille, France; [@bib40]). *Ifnγ^−/−^*, *Ifnγ^−/−^Socs1^−/−^*, *Il17^−/−^*, and *Ifnγr1^−/−^* mice with the C57BL/6J background were described previously ([@bib23]; [@bib10]; [@bib34]). Mice were kept in conventional conditions in Keio University. All experiments using these mice were approved by and performed according to the guidelines of the Animal Ethics Committee of Keio University.

### Histopathologic examination.

Tissue samples were obtained from the proximal and distal colon, skin, liver, and kidneys and then fixed in 10% neutral buffered formalin, embedded in paraffin, and stained with hematoxylin and eosin (H&E). Assessments of the severity of colitis were performed using the histopathologic score as described previously ([@bib13]).

### In vivo suppression assay and transfer colitis model in *Rag2^−/−^* mice.

Flow cytometry--purified 4 × 10^5^ CD4^+^CD25^−^CD62L^+^CD44^−^ naive T cells from WT mice were injected intravenously into *Rag2^−/−^* mice in combination with 2 × 10^5^ CD3^+^CD4^+^CD25^+^Foxp3^GFP^ cells from WT-*Foxp3^GFP^* or cKO-*Foxp3^GFP^* mice (8 wk old and sex matched) or 2 × 10^5^ CD3^+^CD4^+^CD25^bright^ T~reg~ cells from *Ifnγ^−/−^Socs1^+/+^* or *Ifnγ^−/−^Socs1^−/−^* mice (8 wk old and sex matched). Mice were observed daily and weighed weekly. 4 wk after cell transfer, the mice were sacrificed for experiments, and colon sections were stained with H&E. Tissues were graded semiquantitatively. Histological grades were assigned in a blinded manner.

### Transfer of T~reg~ cells into *Rag2^−/−^* mice.

Flow cytometry--purified 2 × 10^5^ CD3^+^CD4^+^CD25^+^Foxp3^GFP^ cells from WT-*Foxp3^GFP^* or cKO-*Foxp3^GFP^* mice (8 wk old and sex matched) or 2 × 10^5^ CD3^+^CD4^+^CD25^bright^ T~reg~ cells from *Ifnγ^−/−^Socs1^+/+^* or *Ifnγ^−/−^Socs1^−/−^* mice (8 wk old and sex matched) were injected intravenously into *Rag2^−/−^* mice. Mice were observed daily and weighed weekly. 6 wk after cell transfer, the mice were sacrificed for experiments.

### Flow cytometry, cell sorting, and cytokine secretion assays.

Cell surface staining and flow cytometric analysis of CD3, CD4, CD25, CD62L, and CD44 (all from eBioscience) expression were performed as described previously ([@bib9]). For the isolation of T~reg~ cells, CD4^+^ T cells were positively selected with magnetic-activated cell sorting (Miltenyi Biotec), and CD3^+^CD4^+^CD25^+^Foxp3^GFP^ cells or CD3^+^CD4^+^CD25^bright^ cells were further purified using a FACSAria cell sorter (BD). The purity of the sorted populations was invariably \>99%. Intracellular staining of Foxp3, IL-2, IFN-γ, IL-17A, and CTLA4 (all from eBioscience) was performed after fixation and permeabilization according to the manufacturer's instructions. To measure T cell cytokine production, cells were stimulated with 50 ng/ml PMA and 250 ng/ml ionomycin in the presence of Golgi Plug (BD) for 4 h at 37°C before staining. For phospho-STAT1 and phospho-STAT3 staining, Phosflow Lyse/Perm buffer and Perm Buffer III (BD) were used according to the manufacturer's instructions.

### In vitro culture of T~reg~ cells.

To examine effector T cell differentiation, 10^5^ T~reg~ cells/well (CD3^+^CD4^+^CD25^+^ Foxp3^GFP^ cells or CD3^+^CD4^+^CD25^bright^ cells) from WT-*Foxp3^GFP^*, cKO-*Foxp3^GFP^*, *Ifnγ^−/−^Socs1^+/+^*, or *Ifnγ^−/−^Socs1^−/−^* mice (8 wk old and sex matched) were stimulated with anti-CD3/anti-CD28 mAb--coated beads (Dynal) at a 1:1 cell/bead ratio for 72 h, with 10 ng/ml IL-2 in 96-well, flat-bottom plates.

### In vitro effector T cell differentiation with supernatants of cultured T~reg~ cells.

3 × 10^5^ WT naive T cells/well were cultured for 5 d without, with LPS-untreated, or with 1 µg/ml LPS--stimulated APCs (7 × 10^5^ T cell--depleted spleen cells/well) and supernatants from 2-d cultured 2 × 10^5^ *Socs1^+/+^*, *Socs1^−/−^*, and *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells/well. Flow cytometric analysis of IFN-γ and IL-17A was performed on these cells. These were also observed with 10 µg/ml anti--IFN-γ, --IL-12, --IL-17, --IL-6, --TGF-β, or --IL-23 antibodies.

### Cytokine detection.

Supernatants from cultures of T~reg~ cells with or without the indicated cytokines were harvested and pooled. Where indicated, 20 ng/ml IL-1α, 20 ng/ml IL-1β, 40 ng/ml IL-6, 50 ng/ml IL-12, 50 ng/ml IL-23, and 10 µg/ml anti--TGF-β mAb (1D11) were added. IFN-γ and IL-17A concentrations were measured using commercially available mouse ELISA Ready-S (eBioscience). All samples were run in triplicate.

### Western blot analysis.

Cell lysates from T~reg~ cells (2 × 10^5^ cells) from WT-*Foxp3^GFP^*, cKO-*Foxp3^GFP^*, *Ifnγ^−/−^Socs1^+/+^*, and *Ifnγ^−/−^Socs1^−/−^* mice were resolved by SDS-PAGE subjected to Western blot analysis. The membranes were immunoblotted with various antibodies, and the bound antibodies were visualized with horseradish peroxidase--conjugated antibodies against rabbit or mouse IgG (Jackson ImmunoResearch Laboratories, Inc.), using Chemi-Lumi One Super Western blotting detection reagents (Nacalai Tesque). Antibodies against STAT1, phospho-STAT1, STAT3, phospho-STAT3 (all from Cell Signaling Technology), and tubulin (Sigma-Aldrich) were used to visualize the corresponding proteins.

### Reverse transcription PCR analysis.

Total RNA was prepared using a nucleospin RNA XS (MACHEREY-NAGEL). RNA was reverse transcribed to cDNA with random primers (Applied Biosystems) and a high capacity cDNA reverse transcription kit (Applied Biosystems) in accordance with the manufacturer's protocol. To determine the cellular expression level of each gene, quantitative real-time PCR analysis was performed using a C1000 Thermal Cycler (Bio-Rad Laboratories). The PCR mixture consisted of 5 µl of KAPA SYBR FAST qPCR kits (Kapa Biosystems), 15 pmol of forward and reverse primers, and the cDNA samples in a total volume of 10 µl. Relative RNA abundance was determined based on control-HPRT abundance.

### Bisulfite sequencing.

Genomic DNA extracted from freshly isolated or 3-d cultured 2 × 10^5^ T~reg~ cells from male WT-*Foxp3^GFP^*, cKO-*Foxp3^GFP^*, *Ifnγ^−/−^Socs1^+/+^*, and *Ifnγ^−/−^Socs1^−/−^* mice (8 wk old and sex matched) was digested with BamHI. 2 × 10^5^ T~reg~ cells from male WT-*Foxp3^GFP^* and cKO-*Foxp3^GFP^* mice before transfer or 4 wk after transfer into *Rag2^−/−^* mice were also examined. H~2~O was added to 500 ng of the digested DNA to a volume of 19 µl, and 1.2 µl of 6N NaOH was added; the mixture was then incubated at 37°C for 15 min. Next, 120 µl of 3.6N Na bisulfite, 0.57 mM hydroquinone, and 0.3N NaOH were added. Samples were then treated with 15 cycles of 95°C for 30 s to 50°C for 15 min. The reaction was then desalted using the Wizard DNA cleanup system (Promega) and eluted with 50 µl TE (Tris-EDTA). 3 µl of 5N NaOH was added, and the samples were incubated for 5 min at room temperature. The products were then ethanol precipitated and dissolved with 50 µl of TE buffer. The CNS2 region was PCR amplified with the primer set (forward, 5′-TTTTGGGTTTTTTTGGTATTTAAGA-3′; reverse, 5′-TTAACCAAATTTTTCTACCATTAAC-3′) and T/A cloned into a pGEM-T-Easy vector (Promega). 10 inserted plasmids from each condition were purified and sequenced. 2 × 10^5^ T~reg~ cells before transfer and 4 wk after transfer into *Rag2^−/−^* mice were also analyzed.

### Statistical analysis.

For statistical analysis, we used the Student's *t* test.

### Online supplemental material.

Fig. S1 shows that the suppressive activity of SOCS1-deficient T~reg~ cells is attenuated in *Rag2^−/−^* mice. Fig. S2 shows colitis caused by SOCS1-deficient T~reg~ cells in *Rag2^−/−^* mice. Fig. S3 shows that the loss of Foxp3 expression in T~reg~ cells is not caused by outgrowth of activated memory T cell contamination of injected donor cells in *Rag2^−/−^* mice. Fig. S4 shows expression levels of IL-10 of T~reg~ cells before and after transfer in *Rag2^−/−^* mice. Fig. S5 shows that the suppressive activity of *Ifnγ^−/−^Socs1^−/−^* T~reg~ cells is attenuated in *Rag2^−/−^* mice. Fig. S6 shows that anti--IFN-γ, --IL-17, --IL-12, and --IL-6 antibodies nearly completely inhibit Th1 and Th17 cell differentiation through APCs. Fig. S7 shows that *Socs1^−/−^* T~reg~ cells cannot suppress colitis induced by the transfer of *Ifnγr1^−/−^* naive T cells into *Rag2^−/−^* mice. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20110428/DC1>.
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